
GLPG 0974
CAS No. 1391076-61-1
GLPG 0974( GLPG0974 )
Catalog No. M11618 CAS No. 1391076-61-1
GLPG 0974 is a potent, selective free fatty acid receptor 2 (FFA2, GPR43) antagonist with IC50 of 95 nM.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 110 | Get Quote |
![]() ![]() |
10MG | 177 | Get Quote |
![]() ![]() |
25MG | 356 | Get Quote |
![]() ![]() |
50MG | 530 | Get Quote |
![]() ![]() |
100MG | Get Quote | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameGLPG 0974
-
NoteResearch use only, not for human use.
-
Brief DescriptionGLPG 0974 is a potent, selective free fatty acid receptor 2 (FFA2, GPR43) antagonist with IC50 of 95 nM.
-
DescriptionGLPG 0974 is a potent, selective free fatty acid receptor 2 (FFA2, GPR43) antagonist with IC50 of 95 nM; inhibits acetate-induced neutrophil migration strongly in vitro with IC50 of 27 nM; demonstrates ability to inhibit a neutrophil-based pharmacodynamic (PD) marker, CD11b activation-specific epitope [AE], in a human whole blood assay.Ulcer,Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsGLPG0974
-
PathwayGPCR/G Protein
-
TargetFFAR
-
RecptorFFAR
-
Research AreaOther Indications
-
IndicationUlcer
Chemical Information
-
CAS Number1391076-61-1
-
Formula Weight484.995
-
Molecular FormulaC25H25ClN2O4S
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 200 mg/mL (412.37 mM)
-
SMILESO=C(O)CCCN(C([C@]1(C)N(C(C2=CSC3=CC=CC=C23)=O)CC1)=O)CC4=CC=CC(Cl)=C4
-
Chemical Name4-[[[(2R)-1-(Benzo[b]thien-3-ylcarbonyl)-2-methyl-2-azetidinyl]carbonyl][(3-chlorophenyl)
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Pizzonero M, et al. J Med Chem. 2014 Dec 11;57(23):10044-57.
2. Sergeev E, et al. J Biol Chem. 2016 Jan 1;291(1):303-17.
3. Namour F, et al. Br J Clin Pharmacol. 2016 Jul;82(1):139-48.
molnova catalog



related products
-
PBI-4050 sodium
PBI-4050 (Setogepram, PBI4050) is a synthetic analog of a medium-chain fatty acid that displays agonist and antagonist ligand affinity toward GPR40 and GPR84, respectively.
-
GLPG 0974
GLPG 0974 is a potent, selective free fatty acid receptor 2 (FFA2, GPR43) antagonist with IC50 of 95 nM.
-
Fasiglifam
A potent, selective, orally bioavailable GPR40 (FFA1) agonist with EC50 of 14 nM.